188 research outputs found

    CT ์ƒ์˜ ๊ธˆ์† ํ—ˆ์ƒ๋ฌผ ์ œ๊ฑฐ๋ฅผ ์œ„ํ•œ ํšจ์œจ์ ์ธ ๋น” ๊ฒฝํ™” ๊ต์ • ์•Œ๊ณ ๋ฆฌ์ฆ˜

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ๊ณต๊ณผ๋Œ€ํ•™ ์ „๊ธฐยท์ปดํ“จํ„ฐ๊ณตํ•™๋ถ€, 2021. 2. ์‹ ์˜๊ธธ.๋น”๊ฒฝํ™”๋Š” ๋‹ค์ƒ‰ X์„ ์„ ์‚ฌ์šฉํ•˜๊ณ  ์—๋„ˆ์ง€ ์˜์กด์ ์ธ ๋ฌผ์งˆ ๊ฐ์‡  ๊ณ„์ˆ˜๋ฅผ ์ด์šฉํ•˜๋Š” CT ์‹œ์Šคํ…œ์˜ ํŠน์„ฑ์ƒ ๋ถˆ๊ฐ€ํ”ผํ•œ ํ˜„์ƒ์ด๋ฉฐ, ์ด๋Š” ํŠนํžˆ ๊ธˆ์† ์˜์—ญ์„ ํฌํ•จํ•˜๋Š” ํ”„๋กœ์ ์…˜ ์ƒ์˜ ๊ฐ’์„ ์˜ค์ธก์ •ํ•˜์—ฌ ๊ฒฐ๊ณผ์ ์œผ๋กœ CT ์˜์ƒ์— ํ—ˆ์ƒ๋ฌผ์„ ์œ ๋ฐœํ•œ๋‹ค. ๊ธˆ์† ํ—ˆ์ƒ๋ฌผ ์ €๊ฐํ™”๋Š” CT ์˜์ƒ์— ์กด์žฌํ•˜๋Š” ์ด๋Ÿฌํ•œ ํ—ˆ์ƒ๋ฌผ์„ ์ œ๊ฑฐํ•˜๊ณ  ๊ฐ€๋ ค์ง„ ์‹ค์ œ ์ •๋ณด๋ฅผ ๋ณต์›ํ•˜๋Š” ๊ณผ์ •์ด๋‹ค. ์˜์ƒ์„ ํ†ตํ•œ ์ง„๋‹จ๊ณผ ๋ฐฉ์‚ฌ์„ ์น˜๋ฃŒ๋ฅผ ์œ„ํ•œ ๊ณ„ํš ์ˆ˜๋ฆฝ์— ์žˆ์–ด์„œ ์ •ํ™•ํ•œ CT ์˜์ƒ์„ ํš๋“ํ•˜๊ธฐ ์œ„ํ•ด ๊ธˆ์† ํ—ˆ์ƒ๋ฌผ์˜ ์ œ๊ฑฐ๋Š” ํ•„์ˆ˜์ ์ด๋‹ค. ๋ฐ˜๋ณต์ ์ธ ์žฌ๊ตฌ์„ฑ์— ์˜ํ•œ ์ˆ˜์น˜์  ๋ฐฉ๋ฒ•์— ๊ธฐ๋ฐ˜์„ ๋‘” ํšจ๊ณผ์ ์ธ ๊ธˆ์† ํ—ˆ์ƒ๋ฌผ ์ œ๊ฑฐ์— ๊ด€ํ•œ ์ตœ์‹  ์—ฐ๊ตฌ๋“ค์ด ๋ฐœํ‘œ๋˜์—ˆ์œผ๋‚˜ ๋ฌด๊ฑฐ์šด ๊ณ„์‚ฐ๋Ÿ‰์œผ๋กœ ์ธํ•ด ์ž„์ƒ ์‹ค์Šต์— ์ ์šฉ์ด ์–ด๋ ค์šด ์ƒํ™ฉ์ด๋‹ค. ๋ณธ ๋…ผ๋ฌธ์—์„œ๋Š” ์ด๋Ÿฌํ•œ ๊ณ„์‚ฐ์ ์ธ ์ด์Šˆ๋ฅผ ํ•ด๊ฒฐํ•˜๊ธฐ ์œ„ํ•œ ํšจ์œจ์ ์ธ ๋น” ๊ฒฝํ™” ์ถ”์ • ๋ชจ๋ธ๊ณผ ์ด๋ฅผ ์ด์šฉํ•œ ๊ธˆ์† ํ—ˆ์ƒ๋ฌผ ์ €๊ฐํ™” ๋ฐฉ๋ฒ•์„ ์ œ์•ˆํ•œ๋‹ค. ์ œ์•ˆํ•œ ๋ชจ๋ธ์€ ๊ธˆ์† ๋ฌผ์ฒด์˜ ๊ธฐํ•˜์ •๋ณด์™€ ๋‹ค์ƒ‰ X์„ ์ด ๋ฌผ์ฒด๋ฅผ ํ†ต๊ณผํ•˜๋ฉด์„œ ๋ฐœ์ƒํ•˜๋Š” ๋น”๊ฒฝํ™”์˜ ๋ฌผ๋ฆฌ์ ์ธ ํŠน์„ฑ์„ ๋ฐ˜์˜ํ•œ๋‹ค. ๋ชจ๋ธ์— ํ•„์š”ํ•œ ๋Œ€๋ถ€๋ถ„์˜ ๋งค๊ฐœ๋ณ€์ˆ˜๋“ค์€ ์ˆ˜์น˜ํ•™์ ์ธ ๋ฐฉ๋ฒ•์œผ๋กœ ๊ต์ • ์ „์˜ CT ์˜์ƒ๊ณผ CT ์‹œ์Šคํ…œ์œผ๋กœ๋ถ€ํ„ฐ ์ถ”๊ฐ€์ ์ธ ์ตœ์ ํ™” ๊ณผ์ • ์—†์ด ํš๋“ํ•œ๋‹ค. ๋น”๊ฒฝํ™” ํ—ˆ์ƒ๋ฌผ๊ณผ ๊ด€๋ จ๋œ ๋งค๊ฐœ ๋ณ€์ˆ˜ ์ค‘ ๋‹จ ํ•˜๋‚˜๋งŒ ์žฌ๊ตฌ์„ฑ ์ดํ›„์˜ ์˜์ƒ ๋‹จ๊ณ„์—์„œ ์„ ํ˜• ์ตœ์ ํ™”๋ฅผ ํ†ตํ•ด ํƒ์ƒ‰๋œ๋‹ค. ๋˜ํ•œ ์ œ์•ˆํ•œ ๋ฐฉ๋ฒ•์œผ๋กœ ๊ต์ •๋œ ๊ฒฐ๊ณผ ์˜์ƒ์— ์ž”์กดํ•˜๋Š” ํ—ˆ์ƒ๋ฌผ๋“ค์„ ์ œ๊ฑฐํ•˜๊ธฐ ์œ„ํ•œ ์ถ”๊ฐ€์ ์ธ ๋‘๊ฐ€์ง€ ๊ฐœ์„  ๋ฐฉ๋ฒ•์„ ์ œ์‹œํ•œ๋‹ค. ๋‹ค์ˆ˜์˜ ์‹œ๋ฎฌ๋ ˆ์ด์…˜ ๋ฐ์ดํ„ฐ์™€ ์‹ค์ œ ๋ฐ์ดํ„ฐ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ์ •์„ฑ์  ๋ฐ ์ •๋Ÿ‰์  ๋น„๊ต๋ฅผ ํ†ตํ•ด ์ œ์•ˆ ๊ธฐ๋ฒ•์˜ ์œ ํšจ์„ฑ์ด ์ฒด๊ณ„์ ์œผ๋กœ ํ‰๊ฐ€๋˜์—ˆ๋‹ค. ์ œ์•ˆ ์•Œ๊ณ ๋ฆฌ์ฆ˜์€ ์ •ํ™•์„ฑ ๋ฐ ๊ฒฌ๊ณ ์„ฑ ์ธก๋ฉด์—์„œ ์œ ์˜๋ฏธํ•œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์—ฌ์ฃผ์—ˆ๊ณ , ๊ธฐ์กด์˜ ๊ธฐ๋ฒ•๋“ค์— ๋น„ํ•ด ํ–ฅ์ƒ๋œ ๊ฒฐ๊ณผ ์˜์ƒ์˜ ํ’ˆ์งˆ ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ์ž„์ƒ์ ์œผ๋กœ ์ ์šฉํ• ๋งŒํ•œ ๋น ๋ฅธ ์ˆ˜ํ–‰ ์‹œ๊ฐ„์„ ๋ณด์—ฌ์ฃผ์—ˆ๋‹ค. ์ด ์—ฐ๊ตฌ๋Š” CT ์˜์ƒ์„ ํ†ตํ•œ ์ง„๋‹จ๊ณผ ๋ฐฉ์‚ฌ๋Šฅ ์น˜๋ฃŒ์˜ ๊ณ„ํš ์ˆ˜๋ฆฝ์„ ์œ„ํ•œ ์ •ํ™•์„ฑ ํ–ฅ์ƒ์— ์œ ์˜๋ฏธํ•œ ์˜๋ฏธ๋ฅผ ๊ฐ–๋Š”๋‹ค.Beam hardening in X-ray computed tomography (CT) is an inevitable problem due to the characteristics of CT system that uses polychromatic X-rays and energy-dependent attenuation coefficients of materials. It causes artifacts in CT images as the result of underestimation on the projection data, especially on metal regions. Metal artifact reduction is the process of reducing the artifacts in CT and restoring the actual information hidden by the artifacts. In order to obtain exact CT images for more accurate diagnosis and treatment planning on radiotherapy in clinical fields, it is essential to reduce metal artifacts. State-of-the-art approaches on effectively reducing metal artifact based on numerical methods by iterative reconstruction have been presented. However, it is difficult to be applied in clinical practice due to a heavy computational burden. In this dissertation, we proposes an efficient beam-hardening estimation model and a metal artifact reduction method using this model to address this computational issue. The proposed model reflects the geometric information of metal objects and physical characteristics of beam hardening during the transmission of polychromatic X-ray through a material. Most of the associated parameters are numerically obtained from an initial uncorrected CT image and CT system without additional optimization. Only the unknown parameter related to beam-hardening artifact is fine-tuned by linear optimization, which is performed only in the reconstruction image domain. Two additional refinement methods are presented to reduce residual artifacts in the result image corrected by the proposed metal artifact reduction method. The effectiveness of the proposed method was systematically assessed through qualitative and quantitative comparisons using numerical simulations and real data. The proposed algorithm showed significant results in the aspects of accuracy and robustness. Compared to existing methods, it showed improved image quality as well as fast execution time that is clinically applicable. This work may have significant implications in improving the accuracy of diagnosis and treatment planning for radiotheraphy through CT imaging.Chapter 1 Introduction 1 1.1 Background and motivation 1 1.2 Scope and aim 5 1.3 Main contribution 6 1.4 Contents organization 8 Chapter 2 Related Works 9 2.1 CT physics 9 2.1.1 Fundamentals of X-ray 10 2.1.2 CT reconstruction algorithms 13 2.2 CT artifacts 18 2.2.1 Physics-based artifacts 19 2.2.2 Patient-based artifacts 21 2.3 Metal artifact reduction 22 2.3.1 Sinogram-completion based MAR 24 2.3.2 Sinogram-correction based MAR 27 2.3.3 Deep-learning based MAR 29 2.4 Summary 31 Chapter 3 Constrained Beam-hardening Estimator for Polychromatic X-ray 33 3.1 Characteristics of polychromatic X-ray 34 3.2 Constrained beam-hardening estimator 35 3.3 Summary 41 Chapter 4 Metal Artifact Reduction with Constrained Beam-hardening Estimator 43 4.1 Metal segmentation 44 4.2 X-ray transmission length 46 4.3 Artifact reduction with CBHE 48 4.3.1 Artifact estimation for a single type of metal 48 4.3.2 Artifact estimation for multiple types of metal 51 4.4 Refinement methods 54 4.4.1 Collaboration with ADN 54 4.4.2 Application of CBHE to bone 57 4.5 Summary 59 Chapter 5 Experimental Results 61 5.1 Data preparation and quantitative measures 62 5.2 Verification on constrained beam-hardening estimator 67 5.2.1 Accuracy 67 5.2.2 Robustness 72 5.3 Performance evaluations 81 5.3.1 Evaluation with simulated phantoms 81 5.3.2 Evaluation with hardware phantoms 86 5.3.3 Evaluation on refinement methods 91 Chapter 6 Conclusion 95 Bibliography 101 ์ดˆ๋ก 115 Acknowledgements 117Docto

    C57BL/6 ๋งˆ์šฐ์Šค์—์„œ์˜ ์ •์œ„์ด์‹ ์—ญํ˜•์„ฑ ๊ฐ‘์ƒ์„ ์•” ๋ชจ๋ธ ๊ตฌ์ถ• ๋ฐ ์ข…์–‘ ๋ฉด์—ญ ๋ฏธ์„ธํ™˜๊ฒฝ ๋ถ„์„

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ์˜๊ณผ๋Œ€ํ•™ ์˜ํ•™๊ณผ, 2023. 8. ์ด๊ทœ์–ธ.์„œ๋ก : ๋ฉด์—ญ์ข…์–‘ํ•™์—์„œ ๋งˆ์šฐ์Šค ๋ชจ๋ธ์„ ํ™•๋ณดํ•˜๋Š” ๊ฒƒ์€ ์ƒˆ๋กœ์šด ์น˜๋ฃŒ ๋Œ€์ƒ์„ ์‹๋ณ„ํ•˜๊ณ  ๊ฒ€์ฆํ•˜๋Š”๋ฐ ์ค‘์š”ํ•˜๋‹ค. C57BL/6 ๋งˆ์šฐ์Šค๋Š” ๋™๋ฌผ์˜ ๋ฉด์—ญ์ฒด๊ณ„ ์ค‘ ๊ฐ€์žฅ ํŠน์„ฑํ™”๋œ ๊ฒƒ ์ค‘ ํ•˜๋‚˜๋กœ, ๋ฉด์—ญ์ข…์–‘ํ•™์—์„œ ์ƒˆ๋กœ์šด ๋ฐœ๊ฒฌ์„ ์œ„ํ•œ ๊ฐ€์žฅ ํšจ๊ณผ์ ์ธ ํ”Œ๋žซํผ์„ ์ œ๊ณตํ•œ๋‹ค. TBP3743(๋งˆ์šฐ์Šค ๊ฐ‘์ƒ์„  ์—ญํ˜•์„ฑ์•”) ์„ธํฌ๋ฅผ B6129SF1 ํ•˜์ด๋ธŒ๋ฆฌ๋“œ ๋งˆ์šฐ์Šค์— ์‚ฌ์šฉํ•˜์—ฌ ์ •์œ„์ด์‹ ๋ชจ๋ธ์ด ๊ตฌ์ถ•๋˜์—ˆ์œผ๋ฉฐ, ์ด ๋ชจ๋ธ์€ C57BL/6 ๊ณ„ํ†ต ๋งˆ์šฐ์Šค์— ๋น„ํ•ด ์ข…์–‘ ๋ฉด์—ญํ•™ ์—ฐ๊ตฌ์— ์žˆ์–ด์„œ ์ œํ•œ ๋œ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” C57BL/6 ๋งˆ์šฐ์Šค์—์„œ ์ƒˆ๋กœ์šด ์ •์œ„์ด์‹ ATC ๋ชจ๋ธ์„ ๊ตฌ์ถ•ํ•˜๊ณ , ํ•ด๋‹น ๋ชจ๋ธ์—์„œ ์ข…์–‘ ๋ฏธ์„ธํ™˜๊ฒฝ์˜ ๋ฉด์—ญํŠน์„ฑ์„ ์ค‘์‹ฌ์œผ๋กœ ์—ฐ๊ตฌ๋ฅผ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ๋ฐฉ๋ฒ•: Adapted TBP3743 ์„ธํฌ๋Š” C57BL/6 ๋งˆ์šฐ์Šค์—์„œ in vivo serial passaging์„ ํ†ตํ•˜์—ฌ ๋งŒ๋“ค์–ด์กŒ๋‹ค. ๊ทธ๋ฆฌ๊ณ  ๋‹ค์Œ๊ณผ ๊ฐ™์ด ๋งˆ์šฐ์Šค ๊ฐ‘์ƒ์„ ์— ์ •์œ„์ด์‹ ํ•˜์˜€๋‹ค: original TBP3743 ์„ธํฌ๋ฅผ ์ฃผ์ž…ํ•œ B6129SF1 ๋งˆ์šฐ์Šค (original/129), adapted TBP3743 ์„ธํฌ๋ฅผ ์ฃผ์ž…ํ•œ B6129SF1 ๋งˆ์šฐ์Šค (adapted/129) ๋ฐ adapted TBP3743 ์„ธํฌ๋ฅผ ์ฃผ์ž…ํ•œ C57BL/6 ๋งˆ์šฐ์Šค (adapted/B6). ๊ฒฐ๊ณผ: Adapted TBP3743 ์„ธํฌ๋Š” ์ฒด์™ธ์—์„œ ์„ธํฌ ๋ชจ์–‘, ์ƒ์กด์œจ, ์ด๋™/์นจ์Šต ๋Šฅ๋ ฅ์€ original TBP3743 ์„ธํฌ์™€ ๋น„๊ตํ•˜์˜€์„ ๋•Œ ๋น„์Šทํ•˜์˜€๋‹ค. Ki-67+ ์„ธํฌ ๋ถ„ํš์€ original/129์— ๋น„ํ•ด adapted/129์—์„œ ๋” ๋†’์€ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์˜€๋‹ค. ์ •์œ„์ด์‹ ์ข…์–‘ RNA sequencing ๋ฐ์ดํ„ฐ ๋ถ„์„์„ ํ†ตํ•˜์—ฌ adapted/129๋Š” original/129์— ๋น„ํ•˜์—ฌ ๋” ๊ฐ•ํ•œ oncogenic properties๋ฅผ ๋ณด์—ฌ์ฃผ์—ˆ๋‹ค. ๋ฐ˜๋ฉด, adapted/B6์—์„œ ์„ฑ์žฅํ•œ ์ •์œ„์ด์‹ ์ข…์–‘์€ adapted/129๋ณด๋‹ค ํฌ๊ธฐ๊ฐ€ ์ž‘๊ณ  ๋‚ฎ์€ Ki-67+ ์„ธํฌ ๋ถ„ํš์„ ๋ณด์˜€๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ adapted/B6์™€ adapted/129์—์„œ์˜ oncogenic properties๋Š” ์œ ์‚ฌํ–ˆ๋‹ค. Immune-related pathways๋Š” adapted/B6์—์„œ adapted/129์™€ ๋น„๊ตํ•˜์—ฌ ํ’๋ถ€ํ•˜๊ฒŒ ๋ฐœํ˜„๋˜์—ˆ๋‹ค. ์ •์œ„์ด์‹ ์ข…์–‘์˜ ์œ ์„ธํฌ๋ถ„์„ ๊ฒฐ๊ณผ, adapted/B6์—์„œ ์„ธํฌ๋…์„ฑ CD8+ T์„ธํฌ์™€ monocytic-myeloid-derived suppressor ์„ธํฌ ๋ถ„ํš์ด ๋ชจ๋‘ adapted/129๋ณด๋‹ค ๋†’์•˜๋‹ค. adapted/B6์—์„œ ์ถ”์ •๋œ CD8+ ๋ฐ CD4+ ์„ธํฌ ๋ถ„ํš์€ ์ธ๊ฐ„ ATC์—์„œ์™€ ์œ ์‚ฌํ•˜์ง€๋งŒ original/B6์—์„œ๋Š” ๋ฌด์‹œํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๊ฒฐ๋ก : ์œ„ ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•ด C57BL/6 ๋งˆ์šฐ์Šค์—์„œ ์—ญํ˜•์„ฑ ๊ฐ‘์ƒ์„  ์•”์˜ ์ƒˆ๋กœ์šด ์ •์œ„์ด์‹ ๋ชจ๋ธ์„ ์„ฑ๊ณต์ ์œผ๋กœ ์ˆ˜๋ฆฝํ•˜์˜€๋‹ค. ๊ธฐ์กด์˜ B6129SF1 ๋งˆ์šฐ์Šค ๋ชจ๋ธ๊ณผ ๋น„๊ตํ•˜๋ฉด, ์ด ๋ชจ๋ธ์€ ๋” ๊ณต๊ฒฉ์ ์ธ ์ข…์–‘ํŠน์„ฑ๊ณผ ๊ฐ•๋ ฅํ•œ ๋ฉด์—ญ๋ฐ˜์‘์„ ๋‚˜ํƒ€๋‚ธ๋‹ค. ๋˜ํ•œ ์ด ๋ชจ๋ธ์€ ์ข…์–‘์˜ ๋ฏธ์„ธํ™˜๊ฒฝ์„ ๋” ๊นŠ์ด ์—ฐ๊ตฌํ•˜๋Š”๋ฐ ํ™œ์šฉ๋˜๊ณ , ์ƒˆ๋กœ์šด ํ•ญ์•”์ œ ๊ฐœ๋ฐœ์„ ์œ„ํ•œ ํ”Œ๋žซํผ์œผ๋กœ์„œ ์ž‘์šฉํ•  ๊ฒƒ์ด๋‹ค.Background: Securing a well-established mouse model is important in identifying and validating new therapeutic targets for immuno-oncology. The C57BL/6 mouse is one of the most fully characterised immune system of any animal and provides powerful platform for immuno-oncology discovery. An orthotopic tumor model has been established using TBP3743 (murine anaplastic thyroid cancer [ATC]) cells in B6129SF1 hybrid mice, this model has limited data on tumor immunology than C57BL/6 inbred mice. This study aimed to establish a novel orthotopic ATC model in C57BL/6 mice and characterize the tumor microenvironment focusing immunity in the model. Methods: Adapted TBP3743 cells were generated via in vivo serial passaging in C57BL/6 mice. Subsequently, the following orthotopic tumor models were established via intrathyroidal injection: B6129SF1 mice injected with original TBP3743 cells (original/129), B6129SF1 mice injected with adapted cells (adapted/129), and C57BL/6 mice injected with adapted cells (adapted/B6). Results: The adapted TBP3743 cells de-differentiated but exhibited cell morphology, viability, and migration/invasion potential comparable with those of original cells in vitro. The adapted/129 contained a higher Ki-67+ cell fraction than the original/129. RNA sequencing data of orthotopic tumors revealed enhanced oncogenic properties in the adapted/129 compared with those in the original/129. In contrast, the orthotopic tumors grown in the adapted/B6 were smaller, with a lower Ki-67+ cell fraction than those in the adapted/129. However, the oncogenic properties of the tumors within the adapted/B6 and adapted/129 were similar. Immune-related pathways were enriched in the adapted/B6 compared with those in the adapted/129. Flow cytometric analysis of the orthotopic tumors revealed higher cytotoxic CD8+ T cell and monocytic-myeloid-derived suppressor cell fractions in the adapted/B6 compared with the adapted/129. The estimated CD8+ and CD4+ cell fractions in the adapted/B6 were similar to those in human ATCs but negligible in the original/B6. Conclusions: A novel orthotopic tumor model of ATC was established in C57BL/6 mice. Compared with the original B6129SF1 murine model, the novel model exhibited more aggressive tumor cell behaviours and strong immune responses. Expect that this novel model contributes to the understanding tumor microenvironment and provides the platform for drug development.Introduction 1 Methods 4 Results 15 Discussion 69 References 76 Abstract in Korean 83๋ฐ•

    ์ œ21๋Œ€ ์ด์„ ์„ ์ค‘์‹ฌ์œผ๋กœ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ํ–‰์ •๋Œ€ํ•™์› ํ–‰์ •ํ•™๊ณผ(ํ–‰์ •ํ•™์ „๊ณต), 2020. 8. ๊ธˆํ˜„์„ญ.๋ณธ ์—ฐ๊ตฌ๋Š” ๊ตญํšŒ์˜์› ์ด์„ ๊ฑฐ์˜ ๋‹น์„  ๊ฒฐ์ • ์š”์ธ์„ ๋ฐํžˆ๋ ค๋Š” ์‹œ๋„์—์„œ ์‹œ์ž‘๋๋‹ค. ๊ทธ ์ค‘์—์„œ๋„ 2020๋…„ 4์›” 15์ผ ์‹ค์‹œ๋œ 21๋Œ€ ์ด์„ ์ด ์ฃผ์š”ํ•œ ์—ฐ๊ตฌ ๋Œ€์ƒ์ด๋ฉฐ, ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น(253๋ช…)๊ณผ ๋ฏธ๋ž˜ํ†ตํ•ฉ๋‹น(236๋ช…)์˜ ์ง€์—ญ๊ตฌ ํ›„๋ณด์ž 489๋ช…์„ ๋Œ€์ƒ์œผ๋กœ ๋ถ„์„ํ–ˆ๋‹ค. ๊ทธ๋™์•ˆ ํ•œ๊ตญ ์ •์น˜์—์„œ๋Š” ์ •๋‹น ๋‚ด ์†Œ์ˆ˜์˜ ์‹ค๋ ฅ์ž๊ฐ€ ๋น„๋ฏผ์ฃผ์ ์ด๊ณ  ๋ถˆํˆฌ๋ช…ํ•œ ๋ฐฉ์‹์œผ๋กœ ๊ตญํšŒ์˜์› ์„ ๊ฑฐ์— ๋‚˜์„ค ํ›„๋ณด์ž๋ฅผ ๊ณต์ฒœํ•˜๋Š” ๊ฒŒ ๋ฌธ์ œ๋กœ ์ง€์ ๋๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ทธ๋Ÿฌํ•œ ๋ฐฉ์‹๋ณด๋‹ค ๊ฒฝ์„ ์„ ํ†ตํ•œ ๋ฐฉ์‹์ด ๊ณผ์ •์˜ ๋ฏผ์ฃผ์„ฑ๋ฟ ์•„๋‹ˆ๋ผ ๊ฒฐ๊ณผ์˜ ํšจ๊ณผ์„ฑ๋„ ๋‹ด๋ณดํ•  ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ๊ฐ€์ •ํ–ˆ๋‹ค. ์‹ค์ œ 253๊ฐœ ์ง€์—ญ๊ตฌ์˜ ์„ ๊ฑฐ ๊ฒฐ๊ณผ๋ฅผ ๋ถ„์„ํ•ด ๊ฒฝ์„ ์„ ํ†ตํ•œ ํ›„๋ณด์ž ๊ณต์ฒœ์€ ์ „๋žต(์šฐ์„ )๊ณต์ฒœ, ๋‹จ์ˆ˜๊ณต์ฒœ ๋“ฑ ๋น„๊ฒฝ์„  ๋ฐฉ์‹๋ณด๋‹ค ๋‹น์„  ๊ฐ€๋Šฅ์„ฑ์ด๋‚˜ ๋“ํ‘œ์œจ ์ œ๊ณ  ์ธก๋ฉด์—์„œ ์œ ๋ฆฌํ•˜๋‹ค๋Š” ๊ฒฐ๋ก ์„ ์–ป์—ˆ๋‹ค. ๊ฒฝ์„ ์˜ ๋ณด๋„ˆ์Šค ํšจ๊ณผ(primary bonus)๊ฐ€ ์กด์žฌํ–ˆ๋˜ ๊ฒƒ์ด๋‹ค. ๋˜ํ•œ 21๋Œ€ ์ด์„ ์—์„œ๋Š” ์—ฌ๋‹น ํ›„๋ณด์ž์ธ์ง€ ์•„๋‹Œ์ง€๊ฐ€ ์„ ๊ฑฐ ๊ฒฐ๊ณผ์— ์ƒ๋‹นํžˆ ํฐ ์˜ํ–ฅ์„ ๋ผ์ณค๋‹ค. ์ฝ”๋กœ๋‚˜๋ฐ”์ด๋Ÿฌ์Šค๊ฐ์—ผ์ฆ-19(COVID-19) ์‚ฌํƒœ ์†์—์„œ ์‹ค์‹œ๋œ ์ด๋ฒˆ ์„ ๊ฑฐ๋Š” ์ •๊ถŒ ์•ˆ์ •๋ก ์ด ์ •๊ถŒ ์‹ฌํŒ๋ก ์„ ์••๋„ํ•ด ์—ฌ๋‹น ํ”„๋ฆฌ๋ฏธ์—„์ด ํฌ๊ฒŒ ์ž‘์šฉํ–ˆ๋‹ค. ๋ฐ˜๋ฉด ํ˜„์ง ๊ตญํšŒ์˜์›์ด ํ˜„์žฌ ์ž์‹ ์˜ ์ง€์—ญ๊ตฌ์— ์ถœ๋งˆํ•  ๋•Œ ์–ป๋Š” ์ด๋ฅธ๋ฐ” ํ˜„์ง ํšจ๊ณผ(incumbency advantage)๋Š” ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜๋‹ค. ๊ทธ๋ฆฌ๊ณ  ํ›„๋ณด์ž ์ˆ˜์™€ ๋‹น์„  ๊ฐ€๋Šฅ์„ฑ์€ ํฐ ์ƒ๊ด€์ด ์—†๋Š” ๊ฒƒ์œผ๋กœ ๋ถ„์„๋๋‹ค. ์‚ฌ์‹ค์ƒ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น๊ณผ ๋ฏธ๋ž˜ํ†ตํ•ฉ๋‹น์˜ ์–‘์ž ๋Œ€๊ฒฐ ๊ตฌ๋„๋กœ ์ด์„ ์ด ์น˜๋Ÿฌ์กŒ๊ธฐ ๋•Œ๋ฌธ์— ๋‹ค๋ฅธ ์ •๋‹น ํ›„๋ณด์ž์˜ ์ˆซ์ž๋Š” ํฐ ์˜๋ฏธ๊ฐ€ ์—†์—ˆ๋˜ ๊ฒƒ์ด๋‹ค.This study investigates the process and outcome of party nominations in National Assembly election in the Republic of Korea. Especially this study reviews how the two main parties - the ruling Democratic Party (DP) and the main opposition United Future Party (UFP) - nominated their candidates running for the 21st general election. And identifies the factors to the electoral victories of individual candidates. This study assumes that the primary effect and ruling party premium and incumbency advantage are factors affecting election. Most of all, focus on the primary effect. In other words, this study analyzes intensively on bottom-up style candidate selection. And estimates the relationship between types of candidate selections and their political outcomes. The findings of this study can be summarized into a few consequences. First, the bonus effect of the primary exist. That is to say, bottom-up style of candidate selection system helps candidates earn more votes and their winning chances. Second, ruling party premium is strong. Many DP candidates won election for the reason that they are member of the ruling party. Third, incumbency advantage was not existing. There are limits to this study. There was no third party threatening the two main parties. And the election was held in the midst of Coronavirus disease 2019 (COVID-19). For that reason, there were other factors as well, but they were not analyzed.์ œ 1 ์žฅ ์„œ๋ก  1 ์ œ 1 ์ ˆ ์—ฐ๊ตฌ์˜ ๋ฐฐ๊ฒฝ๊ณผ ๋ชฉ์  1 ์ œ 2 ์ ˆ ์—ฐ๊ตฌ์˜ ๋Œ€์ƒ๊ณผ ๋ฐฉ๋ฒ• 5 1. ์—ฐ๊ตฌ์˜ ๋Œ€์ƒ 5 2. ์—ฐ๊ตฌ์˜ ๋ฐฉ๋ฒ• 7 ์ œ 2 ์žฅ ์ด๋ก ์  ๋…ผ์˜ ๋ฐ ์„ ํ–‰์—ฐ๊ตฌ์˜ ๊ฒ€ํ†  9 ์ œ 1 ์ ˆ ๋ฏผ์ฃผ์„ฑ๊ณผ ํšจ์œจ์„ฑ 9 ์ œ 2 ์ ˆ ๊ทœ๋ฒ”์  ์—ฐ๊ตฌ 10 1. ๊ณต์ฒœ์˜ ๋ฏผ์ฃผํ™” 10 2. ์ƒํ–ฅ์‹ ๊ณต์ฒœ์˜ ํ•„์š”์„ฑ๊ณผ ๋ฌธ์ œ์  13 3. ๊ทœ๋ฒ”์  ์—ฐ๊ตฌ์˜ ํ•œ๊ณ„ 19 ์ œ 3 ์ ˆ ๊ฒฝํ—˜์  ์—ฐ๊ตฌ 19 1. ๊ณต์ฒœ ๊ณผ์ •์— ๋Œ€ํ•œ ๋ถ„์„ 20 2. ๊ณต์ฒœ ๊ฒฐ๊ณผ์— ๋Œ€ํ•œ ๋ถ„์„ 22 3. ๊ณต์ฒœ ์œ ํ˜•์— ๋”ฐ๋ฅธ ์˜์ •ํ™œ๋™ ๋ถ„์„ 26 ์ œ 3 ์žฅ ์—ฐ๊ตฌ์˜ ์„ค๊ณ„ 29 ์ œ 1 ์ ˆ ์—ฐ๊ตฌ ๋ฌธ์ œ 29 1. ์ •๋‹น ๋‚ด๋ถ€์˜ ์š”์ธ 29 2. ์ •๋‹น ์™ธ๋ถ€์˜ ์š”์ธ 32 3. ํ›„๋ณด์ž ๊ฐœ์ธ์˜ ์š”์ธ 33 ์ œ 2 ์ ˆ ์—ฐ๊ตฌ์˜ ๋ณ€์ˆ˜ 34 1. ์ข…์†๋ณ€์ˆ˜ 34 2. ๋…๋ฆฝ๋ณ€์ˆ˜ 35 3. ํ†ต์ œ๋ณ€์ˆ˜ 35 ์ œ 3 ์ ˆ ์—ฐ๊ตฌ์˜ ๋ชจํ˜• 37 ์ œ 4 ์žฅ ๊ธฐ์ดˆ ๋ถ„์„ 38 ์ œ 1 ์ ˆ ๊ณต์ฒœ ๊ธฐ์ค€ 38 ์ œ 2 ์ ˆ ๊ณต์ฒœ ์œ ํ˜• 40 ์ œ 3 ์ ˆ ์„ ๊ฑฐ ๊ฒฐ๊ณผ 46 ์ œ 5 ์žฅ ์‹ฌ์ธต ๋ถ„์„ 55 ์ œ 1 ์ ˆ ๊ธฐ์ˆ ํ†ต๊ณ„ 55 ์ œ 2 ์ ˆ ๊ฐ€์„ค์˜ ๊ฒ€์ฆ 60 1. ์ •๋‹น ๋‚ด๋ถ€์˜ ์š”์ธ 61 2. ์ •๋‹น ์™ธ๋ถ€์˜ ์š”์ธ 76 3. ํ›„๋ณด์ž ๊ฐœ์ธ์˜ ์š”์ธ 78 4. ํ†ต์ œ๋ณ€์ˆ˜ 80 5. ์—ฐ๊ตฌ ๊ฒฐ๊ณผ์˜ ์š”์•ฝ 81 ์ œ 6 ์žฅ ๊ฒฐ๋ก  83 ์ œ 1 ์ ˆ ์—ฐ๊ตฌ์˜ ์˜์˜ 83 ์ œ 2 ์ ˆ ์—ฐ๊ตฌ์˜ ํ•œ๊ณ„ ๋ฐ ํ–ฅํ›„ ๊ณผ์ œ 85Maste

    Diagnostic Accuracy of Percutaneous Transthoracic Needle Lung Biopsies: A Multicenter Study

    Get PDF
    OBJECTIVE: To measure the diagnostic accuracy of percutaneous transthoracic needle lung biopsies (PTNBs) on the basis of the intention-to-diagnose principle and identify risk factors for diagnostic failure of PTNBs in a multi-institutional setting. MATERIALS AND METHODS: A total of 9384 initial PTNBs performed in 9239 patients (mean patient age, 65 years [range, 20-99 years]) from January 2010 to December 2014 were included. The accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PTNBs for diagnosis of malignancy were measured. The proportion of diagnostic failures was measured, and their risk factors were identified. RESULTS: The overall accuracy, sensitivity, specificity, PPV, and NPV were 91.1% (95% confidence interval [CI], 90.6-91.7%), 92.5% (95% CI, 91.9-93.1%), 86.5% (95% CI, 85.0-87.9%), 99.2% (95% CI, 99.0-99.4%), and 84.3% (95% CI, 82.7-85.8%), respectively. The proportion of diagnostic failures was 8.9% (831 of 9384; 95% CI, 8.3-9.4%). The independent risk factors for diagnostic failures were lesions โ‰ค 1 cm in size (adjusted odds ratio [AOR], 1.86; 95% CI, 1.23-2.81), lesion size 1.1-2 cm (1.75; 1.45-2.11), subsolid lesions (1.81; 1.32-2.49), use of fine needle aspiration only (2.43; 1.80-3.28), final diagnosis of benign lesions (2.18; 1.84-2.58), and final diagnosis of lymphomas (10.66; 6.21-18.30). Use of cone-beam CT (AOR, 0.31; 95% CI, 0.13-0.75) and conventional CT-guidance (0.55; 0.32-0.94) reduced diagnostic failures. CONCLUSION: The accuracy of PTNB for diagnosis of malignancy was fairly high in our large-scale multi-institutional cohort. The identified risk factors for diagnostic failure may help reduce diagnostic failure and interpret the biopsy results.ope

    Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis

    Get PDF
    Objective: This study aimed to investigate the regional amyloid burden and myocardial deformation using T1 mapping and strain values in patients with cardiac amyloidosis (CA) according to late gadolinium enhancement (LGE) patterns. Materials and methods: Forty patients with CA were divided into 2 groups per LGE pattern, and 15 healthy subjects were enrolled. Global and regional native T1 and T2 mapping, extracellular volume (ECV), and cardiac magnetic resonance (CMR)-feature tracking strain values were compared in an intergroup and interregional manner. Results: Of the patients with CA, 32 had diffuse global LGE (group 2), and 8 had focal patchy or no LGE (group 1). Global native T1, T2, and ECV were significantly higher in groups 1 and 2 than in the control group (native T1: 1384.4 ms vs. 1466.8 ms vs. 1230.5 ms; T2: 53.8 ms vs. 54.2 ms vs. 48.9 ms; and ECV: 36.9% vs. 51.4% vs. 26.0%, respectively; all, p < 0.001). Basal ECV (53.7%) was significantly higher than the mid and apical ECVs (50.1% and 50.0%, respectively; p < 0.001) in group 2. Basal and mid peak radial strains (PRSs) and peak circumferential strains (PCSs) were significantly lower than the apical PRS and PCS, respectively (PRS, 15.6% vs. 16.7% vs. 26.9%; and PCS, -9.7% vs. -10.9% vs. -15.0%; all, p < 0.001). Basal ECV and basal strain (2-dimensional PRS) in group 2 showed a significant negative correlation (r = -0.623, p < 0.001). Group 1 showed no regional ECV differences (basal, 37.0%; mid, 35.9%; and apical, 38.3%; p = 0.184). Conclusion: Quantitative T1 mapping parameters such as native T1 and ECV may help diagnose early CA. ECV, in particular, can reflect regional differences in the amyloid deposition in patients with advanced CA, and increased basal ECV is related to decreased basal strain. Therefore, quantitative CMR parameters may help diagnose CA and determine its severity in patients with or without LGE.ope

    Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma

    Get PDF
    Background: Ongoing studies are currently investigating the extent of surgical resection required for subsolid cancers. This study aimed to investigate the predictive factors related to recurrence in patients with clinical stage IA subsolid cancer who underwent either lobectomy or sublobar resection. Methods: This was a prospective multicenter observational study conducted in eight qualifying university teaching hospitals between April 2014 and December 2016. A total of 173 patients with subsolid nodules pathologically confirmed to have primary lung adenocarcinoma and stage IA disease were included in the final analysis. All patients underwent lobectomy, segmentectomy, or wedge resection performed by experienced thoracoscopic surgeons at each site. The surgical procedure was chosen based on the decision of the surgeons involved. The primary endpoint was time to recurrence (TTR). Results: The study population was 43.9% (76 of 173) male with a mean age of 60.7 years. During the median follow-up period of 5.01 years, nine patients (5%) experienced disease recurrence. In the multivariable analysis, tumor size (size โ‰ฅ2 cm) (hazard ratio: 73.717, 95% confidence interval [CI]: 3.635-895.036; p < 0.001) and stage IA3 (hazard ratio: 62.010, 95% CI: 2.837-855.185; p < 0.001) were independent predictors of tumor recurrence. When analyzing the recurrence outcome in patients according to surgical procedure, no significant difference was found in TTR among the three groups (i.e., lobectomy, segmentectomy, and wedge resection; p = 0.99). Conclusions: Patients with radiologically subsolid lung adenocarcinoma measuring <3 cm could be candidates for sublobar resection instead of lobectomy.ope

    LOGIS (LOcalization of Ground-glass-opacity and pulmonary lesions for mInimal Surgery) registry: Design and Rationale

    Get PDF
    Background and purpose: An optimal pulmonary localization technique for video-assisted thoracic surgery (VATS) of small lung nodules has not yet been established. The LOcalization of Ground-glass-opacity and pulmonary lesions for mInimal Surgery (LOGIS) registry aims to establish a multicenter database and investigate the usefulness and safety of localization techniques for small pulmonary lesions in individuals undergoing VATS. Methods/Design: The LOGIS registry is a large-scale, multicenter cohort study, aiming to enroll 825 patients at 10 institutions. Based on the inclusion and exclusion criteria, all study participants with pulmonary lesions indicated for VATS will be screened and enrolled at each site. All study participants will undergo preoperative lesion localization by the hook-wire or lipiodol localization methods according to site-specific methods. Within a few hours of marking, thoracoscopic surgery will be done under general anesthesia by experienced thoracoscopic surgeons. The primary endpoints are the success and complication rates of the two localization techniques. Secondary endpoints include procedure duration, recurrence rate, and all-cause mortality. Study participant enrollment will be completed within 2 years. Procedure success rates and incidence of complications will be analyzed based on computed tomography findings. Procedure duration, recurrence rate, and all-cause mortality will be compared between the two techniques. The study will require 5 years for completion, including 6 months of preparation, 3.5 years for recruitment, and 1 year of follow-up endpoint assessment. Discussion: The LOGIS registry, once complete, will provide objective comparative results regarding the usefulness and safety of the lipiodol and hook-wire localization techniques.ope

    Dual-Energy CT for Pulmonary Embolism: Current and Evolving Clinical Applications

    Get PDF
    Pulmonary embolism (PE) is a potentially fatal disease if the diagnosis or treatment is delayed. Currently, multidetector computed tomography (MDCT) is considered the standard imaging method for diagnosing PE. Dual-energy CT (DECT) has the advantages of MDCT and can provide functional information for patients with PE. The aim of this review is to present the potential clinical applications of DECT in PE, focusing on the diagnosis and risk stratification of PE.ope

    Analysis of Complications of Percutaneous Transthoracic Needle Biopsy Using CT-Guidance Modalities In a Multicenter Cohort of 10568 Biopsies

    Get PDF
    OBJECTIVE: To analyze the complications of percutaneous transthoracic needle biopsy using CT-based imaging modalities for needle guidance in comparison with fluoroscopy in a large retrospective cohort. MATERIALS AND METHODS: This study was approved by multiple Institutional Review Boards and the requirement for informed consent was waived. We retrospectively included 10568 biopsies from eight referral hospitals from 2010 through 2014. In univariate and multivariate logistic analyses, 3 CT-based guidance modalities (CT, CT fluoroscopy, and cone-beam CT) were compared with fluoroscopy in terms of the risk of pneumothorax, pneumothorax requiring chest tube insertion, and hemoptysis, with adjustment for other risk factors. RESULTS: Pneumothorax occurred in 2298 of the 10568 biopsies (21.7%). Tube insertion was required after 316 biopsies (3.0%), and hemoptysis occurred in 550 cases (5.2%). In the multivariate analysis, pneumothorax was more frequently detected with CT {odds ratio (OR), 2.752 (95% confidence interval [CI], 2.325-3.258), p < 0.001}, CT fluoroscopy (OR, 1.440 [95% CI, 1.176-1.762], p < 0.001), and cone-beam CT (OR, 2.906 [95% CI, 2.235-3.779], p < 0.001), but no significant relationship was found for pneumothorax requiring chest tube insertion (p = 0.497, p = 0.222, and p = 0.216, respectively). The incidence of hemoptysis was significantly lower under CT (OR, 0.348 [95% CI, 0.247-0.491], p < 0.001), CT fluoroscopy (OR, 0.594 [95% CI, 0.419-0.843], p = 0.004), and cone-beam CT (OR, 0.479 [95% CI, 0.317-0.724], p < 0.001) guidance. CONCLUSION: Hemoptysis occurred less frequently with CT-based guidance modalities in comparison with fluoroscopy. Although pneumothorax requiring chest tube insertion showed a similar incidence, pneumothorax was more frequently detected using CT-based guidance modalities.ope

    Radiation dose reduction using deep learning-based image reconstruction for a low-dose chest computed tomography protocol: a phantom study

    Get PDF
    Background: The aim of this study was to compare the dose reduction potential and image quality of deep learning-based image reconstruction (DLIR) with those of filtered back-projection (FBP) and iterative reconstruction (IR) and to determine the clinically usable dose of DLIR for low-dose chest computed tomography (LDCT) scans. Methods: Multi-slice computed tomography (CT) scans of a chest phantom were performed with various tube voltages and tube currents, and the images were reconstructed using seven methods to control the amount of noise reduction: FBP, three stages of IR, and three stages of DLIR. For subjective image analysis, four radiologists compared 48 image data sets with reference images and rated on a 5-point scale. For quantitative image analysis, the signal to noise ratio (SNR), contrast to noise ratio (CNR), nodule volume, and nodule diameter were measured. Results: In the subjective analysis, DLIR-Low (0.46 mGy), DLIR-Medium (0.31 mGy), and DLIR-High (0.18 mGy) images showed similar quality to the FBP (2.47 mGy) image. Under the same dose conditions, the SNR and CNR were higher with DLIR-High than with FBP and all the IR methods (all P<0.05). The nodule volume and size with DLIR-High were significantly closer to the real volume than with FBP and all the IR methods (all P<0.001). Conclusions: DLIR can improve the image quality of LDCT compared to FBP and IR. In addition, the appropriate effective dose for LDCT would be 0.24 mGy with DLIR-High. ยฉ Quantitative Imaging in Medicine and Surgery. All rights reserved.ope
    • โ€ฆ
    corecore